These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 11367516)
1. Differential regulation of CD3- and CD28-induced IL-2 and IFN-gamma production by a novel tyrosine kinase inhibitor XR774 from Cladosporium cf. cladosporioides. Sadeghi R; Depledge P; Rawlins P; Dhanjal N; Manic A; Wrigley S; Foxwell B; Moore M Int Immunopharmacol; 2001 Jan; 1(1):33-48. PubMed ID: 11367516 [TBL] [Abstract][Full Text] [Related]
2. Novel reduced benzo[j]fluranthen-3-ones from Cladosporium cf. cladosporioides with cytokine production and tyrosine kinase inhibitory properties. Wrigley SK; Ainsworth AM; Kau DA; Martin SM; Bahl S; Tang JS; Hardick DJ; Rawlins P; Sadheghi R; Moore M J Antibiot (Tokyo); 2001 Jun; 54(6):479-88. PubMed ID: 11513036 [TBL] [Abstract][Full Text] [Related]
3. Ligation of the V7 molecule on T cells blocks anergy induction through a CD28-independent mechanism. Soares LR; Rivas A; Tsavaler L; Engleman EG J Immunol; 1997 Aug; 159(3):1115-24. PubMed ID: 9233604 [TBL] [Abstract][Full Text] [Related]
4. CD28-induced T cell activation. Evidence for a protein-tyrosine kinase signal transduction pathway. Lu Y; Granelli-Piperno A; Bjorndahl JM; Phillips CA; Trevillyan JM J Immunol; 1992 Jul; 149(1):24-9. PubMed ID: 1318900 [TBL] [Abstract][Full Text] [Related]
5. Lymphocyte stimulation by CD3-CD28 enables detection of low T cell interferon-gamma and interleukin-4 production in rheumatoid arthritis. Verhoef CM; Van Roon JA; Vianen ME; Glaudemans CA; Lafeber FP; Bijlsma JW Scand J Immunol; 1999 Oct; 50(4):427-32. PubMed ID: 10520184 [TBL] [Abstract][Full Text] [Related]
7. Molecular pathway profiling of T lymphocyte signal transduction pathways; Th1 and Th2 genomic fingerprints are defined by TCR and CD28-mediated signaling. Smeets RL; Fleuren WW; He X; Vink PM; Wijnands F; Gorecka M; Klop H; Bauerschmidt S; Garritsen A; Koenen HJ; Joosten I; Boots AM; Alkema W BMC Immunol; 2012 Mar; 13():12. PubMed ID: 22413885 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of T cell activation by pharmacologic disruption of the MEK1/ERK MAP kinase or calcineurin signaling pathways results in differential modulation of cytokine production. Dumont FJ; Staruch MJ; Fischer P; DaSilva C; Camacho R J Immunol; 1998 Mar; 160(6):2579-89. PubMed ID: 9510155 [TBL] [Abstract][Full Text] [Related]
9. Differences in the induction of induced human CD4(+) CD25(+) FoxP3(+) T-regulatory cells and CD3(+) CD8(+) CD28(-) T-suppressor cells subset phenotypes in vitro: comparison of phorbol 12-myristate 13-acetate/ionomycin and phytohemagglutinin stimulation. Wang H; Daniel V; Sadeghi M; Opelz G Transplant Proc; 2013 Jun; 45(5):1822-31. PubMed ID: 23769052 [TBL] [Abstract][Full Text] [Related]
10. Activated T lymphocytes regulate hyaluronan binding to monocyte CD44 via production of IL-2 and IFN-gamma. Levesque MC; Haynes BF J Immunol; 2001 Jan; 166(1):188-96. PubMed ID: 11123292 [TBL] [Abstract][Full Text] [Related]
11. Factors affecting the cytokine production of human T cells stimulated by different modes of activation. Harada Y; Watanabe S; Yssel H; Arai K J Allergy Clin Immunol; 1996 Dec; 98(6 Pt 2):S161-73. PubMed ID: 8977524 [TBL] [Abstract][Full Text] [Related]
13. The effect of the CD28 activation pathway on the immunosuppressive action of cyclosporine. Hess AD; Bright EC Transplantation; 1991 Jun; 51(6):1232-40. PubMed ID: 1646506 [TBL] [Abstract][Full Text] [Related]
14. Two distinct mechanisms of interleukin-2 gene expression in human T lymphocytes. June CH; Jackson KM; Ledbetter JA; Leiden JM; Lindsten T; Thompson CB J Autoimmun; 1989 Jun; 2 Suppl():55-65. PubMed ID: 2550020 [TBL] [Abstract][Full Text] [Related]
15. Evidence for the involvement of three distinct signals in the induction of IL-2 gene expression in human T lymphocytes. June CH; Ledbetter JA; Lindsten T; Thompson CB J Immunol; 1989 Jul; 143(1):153-61. PubMed ID: 2543699 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of human T cell activation by novel Src kinase inhibitors is dependent upon the complexity of the signal delivered to the cell. Rapecki S; Allen R J Pharmacol Exp Ther; 2002 Dec; 303(3):1325-33. PubMed ID: 12438558 [TBL] [Abstract][Full Text] [Related]
17. Cyclosporin A increases IFN-gamma production by T cells when co-stimulated through CD28. Rafiq K; Kasran A; Peng X; Warmerdam PA; Coorevits L; Ceuppens JL; Van Gool SW Eur J Immunol; 1998 May; 28(5):1481-91. PubMed ID: 9603452 [TBL] [Abstract][Full Text] [Related]
18. T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression. June CH; Ledbetter JA; Gillespie MM; Lindsten T; Thompson CB Mol Cell Biol; 1987 Dec; 7(12):4472-81. PubMed ID: 2830495 [TBL] [Abstract][Full Text] [Related]
19. Activation of type I protein kinase A during receptor-mediated human T lymphocyte activation. Laxminarayana D; Kammer GM J Immunol; 1996 Jan; 156(2):497-506. PubMed ID: 8543799 [TBL] [Abstract][Full Text] [Related]
20. Impaired CD28-mediated interleukin 2 production and proliferation in stress kinase SAPK/ERK1 kinase (SEK1)/mitogen-activated protein kinase kinase 4 (MKK4)-deficient T lymphocytes. Nishina H; Bachmann M; Oliveira-dos-Santos AJ; Kozieradzki I; Fischer KD; Odermatt B; Wakeham A; Shahinian A; Takimoto H; Bernstein A; Mak TW; Woodgett JR; Ohashi PS; Penninger JM J Exp Med; 1997 Sep; 186(6):941-53. PubMed ID: 9294148 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]